Chiniara Ellen
SEC CIK 1398764 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | CLO | 80.5K | — | $273.3K | 6 | 2023-01-03 | 2025-03-03 |
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
Chiniara Ellen made no open-market trades at KYMR in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-03 | 2025-03-03 | KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | CLO | S - Sale | $30.45 | -2,241 | 80.5K | -3% | -$68.2K |
| D | 2025-03-03 | 2025-03-03 | KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | CLO | A - Grant | $0.00 | +27.5K | 82.3K | +50% | $0 |
| 2025-01-06 | 2025-01-06 | KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | CLO | S - Sale | $41.75 | -3,129 | 54.8K | -5% | -$130.6K | |
| D | 2024-03-04 | 2024-03-01 | KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | CLO | A - Grant | $0.00 | +21.8K | 56.0K | +64% | $0 |
| 2024-01-05 | 2024-01-04 | KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | CLO | S - Sale | $22.58 | -3,295 | 34.2K | -9% | -$74.4K | |
| D | 2023-01-04 | 2023-01-03 | KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | CLO | A - Grant | $0.00 | +37.5K | 37.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations